Navigation Links
AMDL Reaffirms 2008 Guidance and Provides Additional Information
Date:9/15/2008

TUSTIN, Calif., Sept. 15 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), a vertically integrated pharmaceutical company with major operations in China and the US, announced today it is reaffirming guidance for Q3 and FY2008. Additionally, the Company is providing information for the benefit of stockholders in response to the heightened activity in its common stock on the American Stock Exchange (AMEX) in recent days.

While it is the Company's normal policy to not comment on unusual trading activity or changes in the Company's quoted stock price or to provide updated guidance between quarterly conference calls, the Company has recently received numerous inquiries requesting updated guidance in light of recent developments in general market conditions and the China and US pharmaceutical sector.

In response to specific inquiries from stockholders, AMDL is reiterating previously issued guidance and providing additional information as follows:

-- The Company has stated anticipated net sales of $13 million for the third quarter 2008. The Company believes it will achieve this primarily through continued distribution and sales for its top-selling products in China, which have shown consistent returns for the last 8 quarters.

-- The Company reaffirms it is on track to achieve its paramount goal for 2008, which is to once again achieve record annual earnings in 2008 with a 100% increase in sales over 2007. For FY2008 AMDL has targeted net sales ranging between $30 to $38.7 million with gross margins of 46% to 52% -- a 100% increase over the same period in 2007 where the Company achieved gross revenues of $15 million with a gross margin of 54%..

-- Potential revenues for AMDL's ELISA DR-70(R) (FDP) in vitro diagnostic (IVD) test which was approved the US FDA on July 3, 2008 for the monitoring of colorectal cancer are not included in AMDL's 2008 guidance forecast. The Company has presented DR-70 technology to both US and International
'/>"/>

SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Grocery Manufacturers Association: FDA Once Again Reaffirms Safety of Bisphenol A (BPA) for All Consumers
2. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
3. Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
4. Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook
5. Grocery Manufacturers Association: Canadian Risk Assessment Reaffirms Safety of Bisphenol A (BPA) for Adults and Children
6. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
7. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
8. Accipiter Capital Management Reaffirms Its Opposition to the Acquisition of VistaCare, Inc. by Odyssey Healthcare, Inc.
9. Hanger Orthopedic Group, Inc. Announces Senior Leadership Succession Plan and Reaffirms Guidance
10. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
11. New Study of Aspartame Research Reaffirms Safety, Even Among Heaviest Users
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... Three Johns Hopkins University School of Medicine researchers have ... treatments for diabetes, Novo Nordisk announced this month. Of ... Diabetes and Obesity Biologics Science Forum Program, only four ... Johns Hopkins researchers. They are Jonathan Powell, M.D., Ph.D.; ... , Jonathan Powell, a professor of oncology, will ...
(Date:4/18/2014)... psychologists have made a brain-related discovery that could ... , This discovery opens up the possibility that ... a specific brain activity that the researchers have ... Journal of Neuroscience has just published ... an associate professor of psychology and his doctoral ...
(Date:4/18/2014)... A discovery by Northwestern Medicine scientists could lead to ... scarring in people with scleroderma. , Fibrosis, or ... tightening of the skin and lungs can lead to ... The concept for new therapeutic options centers on findings ... Medicine-Rheumatology, who identified the role that a specific protein ...
(Date:4/17/2014)... have identified the first genetic variant specifically associated ... accounting for around 10-15 per cent of all ... of the breast cancer sub-type, called invasive lobular ... causes of this particular kind of breast cancer, ... research, published today (Thursday) in the journal ...
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2
... French . New research presented at the ... DC demonstrates that holmium laser therapy is a safe and ... enlargement of the prostate that affects most men as they ... Health Centre (MUHC), is the longest comprehensive assessment of this ...
... CAA multi-institutional team headed by Ursula Bellugi, professor and ... Salk Institute for Biological Studies, has been awarded a ... of Child Health and Human Development (NICHD) to link ... basis using Williams syndrome as a model. ...
... News) -- ,One graduation ceremony may include thousands of handshakes, ... to increase your risk of exposure to harmful bacteria. ... graduating from schools across the state in 2008 had only ... from scientists at the Johns Hopkins Bloomberg School of Public ...
... report outcomes of surgery for a traumatic nerve injury involving ... to compare the efficacy of different surgical treatments, according to ... in New York. In a second HSS study, investigators say ... hope can be refined and used worldwide. Both studies will ...
... from the University of California, Los Angeles (UCLA), the ... Louisville have used a stimulating electrode array to assist ... with assistance, and, over time, to regain voluntary movements ... array, the researchers have found, stimulate the spinal cord,s ...
... 19 (HealthDay News) -- Hispanic women who suffer domestic ... fivefold increased risk of postpartum depression, U.S. researchers say. ... a stronger predictor of postpartum depression than prenatal depression, ... factor. The study of 210 Hispanic women aged ...
Cached Medicine News:Health News:Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment 2Health News:NIH awards Salk Institute $5.5 million grant to study Williams syndrome 2Health News:Are All Those Handshakes at Graduation Hazardous to Your Health? 2Health News:New tool to measure outcomes could help improve arm surgery for devastating nerve injury 2Health News:New tool to measure outcomes could help improve arm surgery for devastating nerve injury 3Health News:New tool to measure outcomes could help improve arm surgery for devastating nerve injury 4Health News:Caltech research helps paraplegic man stand and move legs voluntarily 2Health News:Caltech research helps paraplegic man stand and move legs voluntarily 3Health News:Caltech research helps paraplegic man stand and move legs voluntarily 4Health News:Caltech research helps paraplegic man stand and move legs voluntarily 5
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... Analysis http://www.reportlinker.com/p01957812/Insulin-Pump-Market--Forecast-–-Worldwide-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Insulin Pumps are gaining ...
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces ... is available in its catalogue: ... Technologies for Advanced Drug Delivery Systems ... http://www.reportlinker.com/p01941928/Global-Markets-and-Technologies-for-Advanced-Drug-Delivery-Systems----Focus-on-Routes-of-Administration.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology ...
(Date:1/14/2014)... 14, 2014  Luminex Corporation (Nasdaq: LMNX ) today ... quarter of 2013 on Monday, February 3, 2014. A press ... close of trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... the operating highlights and financial results for the fourth quarter ...
Breaking Medicine Technology:Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on Routes of Administration 16Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... VANCOUVER, June 21, 2007 /PRNewswire-FirstCall/ - Biotech,Holdings reports ... diabetes drug its support in an overview of,diabetic ... Diabetes,Hoy, the Diabetic Federation's scientific and medical magazine ... of diabetic drugs, written by Dr. Roberto Cepeda,Gonzalez, ...
... -- Orexigen(TM),Therapeutics, Inc. , a biopharmaceutical company ... disorders with an initial focus,on obesity, today ... its lead obesity product candidate Contrave(TM) and ... fat, serum,cholesterol, and triglycerides) and insulin-resistance. The,findings ...
Cached Medicine Technology:Diabetes drug supported by Mexican Diabetes Federation 2Diabetes drug supported by Mexican Diabetes Federation 3Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 2Orexigen Therapeutics to Present Data on Contrave Impact on,Visceral Fat and Insulin Resistance at American Diabetes,Association 67th Scientific Sessions in Chicago June 23 3
The full access underbody blanket is positioned on the procedure table before the patient arrives to the room....
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
The lower body blanket is utilized during surgical procedures covering the head, neck, arms and upper torso of your patient....
Medicine Products: